XGN EXAGEN INC.
Healthcare · Medical Laboratories · Market cap: $105.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $241.2K | $0 |
| 2023-Q1 | $0 | $39.8K |
| 2023-Q2 | $519 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $59.2K |
| 2024-Q1 | $0 | $37.6K |
| 2024-Q2 | $77.6K | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $134.7K | $660.0K |
| 2025-Q1 | $0 | $1.2M |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $200.4K |
| 2025-Q4 | $0 | $375.7K |
| 2026-Q1 | $0 | $103.8K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $148.8K |
| 2026-Q4 | $568.7K | $1.1M |
Bought$1.0M9 buy days
Sold$3.9M18 sell days
Net insider flow-$2.8Mnet selling · 5 years
Latest trade2026-11-13Chernett Jorey
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-13 | Sell | Chernett Jorey | 10% owner | 58,068 | $4.08 | $236.9K | 1 |
| 2026-11-12 | Sell | Chernett Jorey | 10% owner | 109,436 | $4.65 | $508.9K | 1 |
| 2026-11-11 | Buy | Chernett Jorey | 10% owner | 71,315 | $5.23 | $373.0K | 1 |
| 2026-11-10 | Buy | Chernett Jorey | 10% owner | 7,085 | $5.26 | $37.3K | 1 |
| 2026-11-09 | Buy | Chernett Jorey | 10% owner | 8,500 | $6.35 | $54.0K | 1 |
| 2026-11-06 | Sell | Chernett Jorey | 10% owner | 11,265 | $6.14 | $69.2K | 1 |
| 2026-10-19 | Buy | Chernett Jorey | 10% owner | 14,000 | $7.46 | $104.4K | 1 |
| 2026-10-16 | Sell | ABALLI JOHN | CEO | 34,294 | $7.87 | $269.8K | 1 |
| 2026-09-01 | Sell | Black Jeffrey G. | CFO | 20,614 | $7.22 | $148.8K | 1 |
| 2026-03-03 | Sell | ABALLI JOHN | CEO | 15,698 | $3.62 | $56.8K | 1 |
| 2026-02-24 | Sell | ABALLI JOHN | CEO | 11,430 | $3.61 | $41.3K | 1 |
| 2026-02-24 | Sell | Black Jeffrey G. | CFO | 1,584 | $3.61 | $5.7K | 1 |
| 2025-10-16 | Sell | ABALLI JOHN | CEO | 31,787 | $11.82 | $375.7K | 1 |
| 2025-09-02 | Sell | Black Jeffrey G. | CFO | 20,466 | $9.79 | $200.4K | 1 |
| 2025-03-25 | Sell | NMSIC Co-Investment Fund, L.P. | 10% owner | 350,000 | $3.30 | $1.2M | 1 |
| 2024-11-20 | Sell | NMSIC Co-Investment Fund, L.P. | 10% owner | 200,000 | $3.30 | $660.0K | 1 |
| 2024-11-15 | Buy | Black Jeffrey G. | CFO | 22,298 | $2.98 | $66.4K | 1 |
| 2024-11-14 | Buy | ABALLI JOHN | CEO | 24,305 | $2.81 | $68.3K | 1 |
| 2024-05-16 | Buy | ABALLI JOHN | CEO | 40,401 | $1.92 | $77.6K | 1 |
| 2024-03-04 | Sell | Adawi Kamal | CFO | 12,784 | $1.91 | $24.4K | 2 |
| 2024-02-06 | Sell | Adawi Kamal | CFO | 6,738 | $1.95 | $13.1K | 1 |
| 2023-10-17 | Sell | ABALLI JOHN | CEO | 33,819 | $1.75 | $59.2K | 1 |
| 2023-06-15 | Buy | TULLIS JAMES L L | 10% owner | 167 | $3.11 | $519 | 1 |
| 2023-03-02 | Sell | Adawi Kamal | CFO | 3,667 | $2.30 | $8.4K | 1 |
| 2023-02-08 | Sell | Hazeltine Mark | Other C-suite | 5,821 | $2.69 | $15.7K | 1 |
| 2023-02-08 | Sell | Adawi Kamal | CFO | 5,821 | $2.69 | $15.7K | 1 |
| 2022-12-08 | Buy | ABALLI JOHN | CEO | 90,000 | $2.68 | $241.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10% owner | $0 | $1.8M | 2025-03-25 |
| Chernett Jorey | 10% owner | $568.7K | $815.0K | 2026-11-13 |
| ABALLI JOHN | CEO | $387.1K | $802.8K | 2026-10-16 |
| Black Jeffrey G. | CFO | $66.4K | $354.9K | 2026-09-01 |
| Adawi Kamal | CFO | $0 | $61.6K | 2024-03-04 |
| Hazeltine Mark | Other C-suite | $0 | $15.7K | 2023-02-08 |
| TULLIS JAMES L L | 10% owner | $519 | $0 | 2023-06-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.